Pelita Teknologi Global Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Pelita Teknologi Global Tbk. trades at Rp940 (market cap 757.64B, 109.8K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Pelita Teknologi Global Tbk. is far larger — about 4.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Pelita Teknologi Global Tbk. is more actively traded (109.8K versus 71K). Which is the better fit depends on your goals.
| CHIP | OBAT | |
|---|---|---|
Market Cap | 757.64B | 167.37B |
Volume | 109.8K | 71K |
Lot | 1.1K | 710 |
Turnover | 102.4M | 17.51M |
Average Price | 932.65 | 246.63 |
Value | 102.4M | 17.51M |
Indicative Equilibrium Price | 940 | 246 |
Indicative Equilibrium Volume | 3 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Pelita Teknologi Global Tbk (the “Company”) was established based on Notarial Deed No. 3 dated February 24, 2017 of Rumondang Nauli Hutadjulu, S.H., notary in Jakarta. The Company started itscommercial operations in 2021.
Read more on CHIP →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →